Bio-Gene Technology Ltd [ASX:BGT] share price and news 2022

Company Description

Bio-Gene Technology Ltd (BGT) is an Australian agtech development company, with a novel technology platform based on a naturally occurring class of plant compounds known as beta-triketones, that seeks to address the global problems of insecticide resistance and toxicity. Bio-Gene is developing two products Flavocide and Qcide to address the major worldwide problem of insecticide resistance in the areas of public health, crop protection, grain storage, animal health, and consumer applications.

Bio-Gene Technology Ltd belongs to Materials sector and under industry of Fertilizers & Agricultural Chemicals. You can get more information about this company via their website: http://www.Bio-gene.com.au.

This a small cap company with market cap of 21 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 3.53 0
Market 0.85 22.3 1.99 0.84
Sector 1.02 15.5 2.44 0.55

Dividend Growth Chart

The following chart shows you how bgt dividend grows in the recent years.

No data